27
- Categories
- Satellite Symposium
- Satellite Symposium
- Satellite Symposium
Exploring the Role of CDK4/6 Inhibitors in HR+ HER2- Breast Cancer: From the Adjuvant to the Metastatic Setting
-
,
Boston 1-2
Endorsed by: Novartis Pharma Schweiz AG
- Chair:
- Marcus Vetter (KSBL)
-
-
Evidence in Action: How Guidelines and Real-World Data Direct CDK4/6i in Metastatic Breast Cancer
- Presentation time:
- 15 min
Speaker: Marcus Vetter (KSBL)
-
From Trials to Treatment: Integrating CDK4/6i in Early Breast Cancer Care
- Presentation time:
- 15 min
-
Reimagining Cancer Care: Can CDK4/6 Inhibitors Help Reducing the Use of Adjuvant Chemotherapy?
- Presentation time:
- 10 min
Speaker: José Luis Sandoval (HUG)
-
Panel discussion based on patient cases
- Presentation time:
- 15 min